Michael R. Minogue, CEO, President & Chairman of the Board
Dr. Karim Benali, Chief Medical Officer
William J. Bolt, Senior Vice President, Global Quality and Service

Patricia A. Fitch , Vice President, Sales
Andrew J. Greenfield, Vice President, Healthcare Solutions
Dr. Robert T.V. Kung, Senior Vice President and Chief Scientific Officer
Dr. Thorsten Siess, Chief Technology Officer

Dr. David Weber, Chief Operating Officer

Mr. Michael R. Minogueis Abiomed’s Chairman, Chief Executive Officer and President.  He joined Abiomed in April 2004 following a successful twelve-year career at GE Healthcare.  Mr. Minogue departed GE as the Vice President and General Manager of Americas Sales and Marketing for the $1B Information Technology business.  From 1997 to 2004, Mr. Minogue held various global leadership positions in sales, marketing, customer service, engineering management, and software development for GE.  Mr. Minogue led the Positron Emission Technology division, Americas Cardiology Sales and Marketing, Global Installed Base business, and MRI Americas marketing.  Prior to joining GE, Mr. Minogue served on active duty for four years as an infantry officer in the U.S. Army and received multiple awards.  Mr. Minogue received his Bachelor of Science degree in engineering management from the United States Military Academy at West Point and his MBA from the University of Chicago.  Mr. Minogue currently serves on the board of directors for AdvaMed, the Advanced Medical Technology Association, and formerly with LifeCell Corporation (LIFC).  Since joining Abiomed, Mr. Minogue has focused the company on heart recovery in order to treat a broader patient population with new products developed in-house and by acquisition, such as Impella.

Dr. Karim Benali joined ABIOMED in July 2004 as Vice President of Product Development. In January 2006 he became ABIOMED's Chief Medical Officer, leading the Company's upstream product development efforts and strategic clinical research functions. Dr. Benali has more than twelve years of international experience in medicine and research, with a strong focus on cardiology. He held several strategic positions in academic and corporate fields with leading institutions in Europe and has a strong background in the design and supervision of multi-center clinical trials. While at GE HealthCare, he brought to market two of the company's top products in cardiology. As Global Manager of Cardiology-Functional Imaging at GE Healthcare, he led the introduction of breakthrough applications in cardiology, pioneered the first cardiac procedures on the newly introduced hybrid imaging platform and positioned GE as market leader in Cardiac PET/CT. He previously held the position of Global Clinical Research Leader for the Cardiovascular Business at GE Healthcare. Dr. Benali earned a BS degree from the University of Algiers in Engineering Technology, an MD degree from Institut National de l'Enseignement Superieur des Sciences Medicales in Algiers, an MS in Bio-imaging and Bio-engineering from the University of Val de Marne —Paris XII, and a Pierre & Marie Curie University Degree in Biostatistics and Clinical Research —Paris VI.

Mr. William J. Bolt has served ABIOMED since 1982 and has been Senior Vice President for Global Quality and Service since January 2003. He is currently responsible for all Quality and Design Assurance activities in the Company. He was responsible for all product development and the AbioCor program from 2000-2002, and for BVS and AB5000 development from 1999-2002. From 1994 to 1998, he was President of ABIOMED's dental subsidiary, ABIODENT. From 1982 to 1994, he served in various roles, from Vice President of Engineering to Vice President of Operations, where he was the engineer in-charge of the development of the BVS and other systems. Mr. Bolt received his Bachelor's degree in Electrical Engineering and an MBA from Northeastern University.

Ms. Patricia A. Fitch joined ABIOMED in January 2008 as Vice President of Sales, bringing to ABIOMED her expertise in in field sales leadership, sales operations and sales management. Ms. Fitch joined ABIOMED from J&J Cordis Cardiology, where she has been the Director of Sales Operations and Development as well as holding several regional and divisional sales management roles for the past 10 years.  Her earlier experience includes sales responsibilities with Schneider and Baxter Edwards Critical Care.  She holds a Bachelor’s degree in Biology from Purdue University and an MBA from the Carlson School of Business at the University of Minnesota.

Mr. Andrew J. Greenfield joined ABIOMED in January 2005 as Vice President of Healthcare Solutions, bringing to ABIOMED his expertise in six sigma and healthcare consulting. Mr. Greenfield held multiple positions at GE Healthcare from 1999-2005, including consulting with large U.S. health systems in the Enterprise Client Group, Six Sigma Master Black Belt, and Finance Manager. Prior to GE Healthcare, he held multiple positions in marketing and sales management at the Boeing Company including Program Manager and European Country Manager. He received his bachelor degree in finance from the University of Illinois, an MBA from St. Louis University, and is a certified Six Sigma Master Black Belt and change management facilitator.

Mr. Robert T.V. Kung has served ABIOMED since 1982 and has been Senior Vice President and Chief Scientific Officer since 1995. He was Vice President of Research and Development from 1987 to 1995 and Chief Scientist from 1982 to 1987. Prior to joining ABIOMED, Dr. Kung was a Principal Research Scientist at Schafer Associates from 1978 to 1982 and at the Avco Everett Research Laboratory from 1972 to 1978. He developed non-linear optical techniques for laser applications and investigated physical and chemical phenomena in re-entry physics. Dr. Kung has been Principal Investigator for ABIOMED's National Institutes of Health-funded AbioCor and AbioBooster programs and has conceived of and directed the development of ABIOMED's laser-based minimally invasive technologies. Dr. Kung received a Ph.D. degree in Physical Chemistry from Cornell University.

Dr. Thorsten Siess joined ABIOMED in 2005 upon its acquisition of Impella CardioSystems, AG, which he co-founded in 1998 and has served as Manager of R&D, then Chief Technology Officer. His work in the development and marketing of the Impella 2.5 and 5.0 in Europe led to their CE Mark approval. During his time at the University of Aachen he developed the Impella technology which served as a platform for the entire Impella product portfolio. The products, which allow early intervention through a pencil-sized VAD, are now available in 70 centers in 11 countries. Prior to founding Impella, Dr. Siess served as Scientist in the Biomedical Technology Team at Helmholtz-Institute of Biomedicine at the University of Aachen in Germany. Dr. Siess received a Ph.D. degree as well as his MASc in Mechanical Engineering from the University of Aachen.

Dr. David Weber joined Abiomed in 2007 as the Company's Chief Operating Officer. Dr. Weber brings more than 15 years of management experience, including 13 years with GE Healthcare, where he most recently held the position of General Manager of GE Security’s Aviation and Transportation Business. He previously held the position of General Manager of Magnetic Resonance (MR) Marketing, a greater than $1 billion business within GE Medical Systems.  He has also held several positions in marketing, clinical application development and product development. Prior to joining GE, Dr. Weber completed a post-doctoral assignment at the University of Wisconsin in Madison where he received his Master of Science Degree and Ph.D. in Medical Physics. He has Bachelor of Science Degrees in Physics from Denison University and in Nuclear Engineering from Columbia University School of Engineering.